High Katherine A

CIK 00016312483 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001631248

Recent Transactions

50 trades

Award
INCYTE CORP$INCY
Common Stock
2025-06-10+2,518→ 13,341 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2025-06-10+9,216→ 9,216 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Award
INCYTE CORP$INCY
Non Qualfied Stock Option (right to buy)
2024-06-12+12,517→ 12,517 total
Award
INCYTE CORP$INCY
Common Stock
2024-06-12+2,830→ 10,823 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-05-30+13,000→ 13,000 total
Award
INCYTE CORP$INCY
Common Stock
2023-06-14+2,505→ 7,993 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2023-06-14+11,294→ 11,294 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 total
Award
INCYTE CORP$INCY
Common Stock
2022-06-15+2,144→ 5,488 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2022-06-15+9,124→ 9,124 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
INCYTE CORP$INCY
Common Stock
2021-05-26+1,923→ 3,344 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2021-05-26+8,010→ 8,010 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-06-11+15,000→ 15,000 total
Award
INCYTE CORP$INCY
Common Stock
2020-05-26+1,282→ 1,421 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option (right to buy)
2020-05-26+10,514→ 10,514 total
Award
INCYTE CORP$INCY
Non-Qualified Stock Option
2020-03-26+1,285→ 1,285 total
Award
INCYTE CORP$INCY
Common Stock
2020-03-26+139→ 139 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−35,000→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−15,750→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−23,625→ 0 total
Disposition from Tender
Spark Therapeutics, Inc.
Common Stock
2019-12-17$114.50/sh−278,834→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Restricted Stock Units
2019-12-17−21,250→ 0 total
Disposition to Issuer
Spark Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-17−13,750→ 0 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2019-06-11+30,000→ 30,000 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−41,247→ 13,750 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−73,249→ 0 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$40.44/sh+21,247→ 297,753 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-03-21$113.25/sh−31,653→ 256,064 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$3.45/sh+73,249→ 287,717 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-03-21$113.26/sh−11,184→ 276,326 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−64,160→ 0 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-03-21$113.25/sh−49,561→ 276,506 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−3→ 54,997 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−5,840→ 64,160 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-03-21$113.26/sh−5,367→ 278,834 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$40.44/sh+3→ 261,907 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−15,750→ 15,750 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$56.17/sh+15,750→ 287,510 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$50.55/sh+7,875→ 284,201 total
Tax Payment
Spark Therapeutics, Inc.
Common Stock
2019-03-21$113.26/sh−25,993→ 271,760 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$68.45/sh+64,160→ 326,067 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-03-21$68.45/sh+5,840→ 261,904 total
Exercise/Conversion
Spark Therapeutics, Inc.
Stock Option (right to buy)
2019-03-21−7,875→ 23,625 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2019-01-18−2,250→ 6,750 total
Exercise/Conversion
Spark Therapeutics, Inc.
Restricted Stock Units
2019-01-18−2,250→ 4,500 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-01-18+2,250→ 215,151 total
Exercise/Conversion
Spark Therapeutics, Inc.
Common Stock
2019-01-18+2,250→ 213,709 total

Companies

Recent Filings

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127

View on SEC.gov